Post Tagged with: "NASDAQ:LGND"

5 Stock in Different Moves: Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), BCE Inc. (NYSE:BCE), Codorus Valley Bancorp (NASDAQ:CVLY), Financial Engines (NASDAQ:FNGN), SM Energy (NYSE:SM)

February 10, 2015 at 2:45 pm 0 comments

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) reported in-line earnings for the fourth quarter. The La Jolla, California-based company posted a quarterly profit of $7.1 million, or $0.34 per share, versus $1.9 million, or $0.09 per share, in the year-ago period. Non-GAAP netRead More

Volatile Stocks: Advaxis (NASDAQ:ADXS), Ligand Pharmaceuticals (NASDAQ:LGND), ANI Pharmaceuticals (NASDAQ:ANIP), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Alcobra (NASDAQ:ADHD)

February 10, 2015 at 1:42 pm 0 comments

On 28 January, Securities lawyers at Dunnam & Dunnam are investigating allegations for Advaxis, Inc. shareholders (NASDAQ:ADXS). Concerned ADXS investors who purchased between January 7, 2015 and January 20, 2015 are encouraged to contact securities attorney Hamilton Lindley. On MondayRead More

Stocks in Focus: Trina Solar (NYSE:TSL), JP Energy Partners LP (NYSE:JPEP), Ligand Pharmaceuticals (NASDAQ:LGND), Amtech Systems (NASDAQ:ASYS), Eagle Rock Energy Partners (NASDAQ:EROC)

February 9, 2015 at 4:14 pm 0 comments

Trina Solar Limited (NYSE:TSL) announced it will host a conference call on Wednesday, March 4th, 2015 at 8:00 a.m. U.S. Eastern Standard Time (9:00 p.m. Beijing /Hong Kong, March 4th, 2015), to discuss results for the fourth quarter and fullRead More

Stocks in news: CEMEX, S.A.B. de C.V. (NYSE:CX), Exact Sciences (NASDAQ:EXAS), Elizabeth Arden (NASDAQ:RDEN), Ligand Pharmaceuticals (NASDAQ:LGND), Regency Energy Partners (NYSE:RGP)

February 7, 2015 at 4:11 pm 0 comments

CEMEX, S.A.B. de C.V. (NYSE:CX) announced Operating EBITDA on a like-to-like basis increased by 16% during the quarter to U.S.$701. On a like-to-like basis, full-year operating EBITDA increased by 6% to U.S.$2.7 billion. Operating EBITDA margin grew by 1.7 percentageRead More

Stocks Buzz: FireEye (NASDAQ:FEYE), Inc. (NASDAQ:FLWS), Ophthotech Corporation (NASDAQ:OPHT), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Linn Energy, LLC (NASDAQ:LINE)

February 5, 2015 at 10:05 am 0 comments

On 27 Januay, FireEye, Inc. (NASDAQ:FEYE) and Viewfinity announced an integration of Viewfinitiy’s advanced endpoint protection solution with both the FireEye® Threat Analytics Platform™ (TAP™), a cloud-based security analytics platform, and the FireEye AX series, a group of forensic analysisRead More

Big Movers in Focus: EMC Corporation (NYSE:EMC), Nabors Industries (NYSE:NBR), Marcus & Millichap (NYSE:MMI), Ligand Pharmaceuticals (NASDAQ:LGND), General Electric (NYSE:GE)

February 3, 2015 at 10:14 am 0 comments

EMC Corporation (NYSE:EMC), which has been under pressure from activist investor Elliott Management Corp, forecast a lower-than-expected profit for the year and said it would cut jobs. EMC company said on Jan 29, it expected to take a charge ofRead More

Stocks News Alert: Rite Aid Corporation (NYSE:RAD), The Walt Disney Company (NYSE:DIS), The Dow Chemical Company (NYSE:DOW), Venaxis (NASDAQ:APPY), Ligand Pharmaceuticals (NASDAQ:LGND)

January 30, 2015 at 2:31 pm 0 comments

Rite Aid Corporation (NYSE:RAD) plans to open a new distribution center in Spartanburg, SC. Located near the I-85 Corridor, the new 900,000 square foot distribution center will employ a staff of 600. On Thursday shares of Rite Aid Corporation (NYSE:RAD)Read More

Must Watch These 5 Stocks: Pfizer Inc. (NYSE:PFE), Esperion Therapeutics (NASDAQ:ESPR), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Verisk Analytics (NASDAQ:VRSK), Arotech (NASDAQ:ARTX)

January 22, 2015 at 1:58 pm 0 comments

On 15 January Pfizer Inc. (NYSE:PFE) stepping up research on drugs that use the immune system to attack tumors, seeking to catch up to Merck & Co. and Bristol-Myers Squibb Co. (BMY) in one of the industry’s most promising categories.Read More

Biotech Insider Buying to Watch: Arrowhead Research Corp. (NASDAQ:ARWR), VIVUS Inc. (NASDAQ:VVUS), CorMedix (NYSEMKT: CRMD), Synageva BioPharma (NASDAQ:GEVA), Ligand Pharmaceuticals (NASDAQ:LGND)

January 15, 2015 at 2:27 pm 0 comments

On 12 January Arrowhead Research Corp. (NASDAQ:ARWR) announced that the U.S. Food and Drug Administration (FDA) verbally informed the Company in a preliminary call of a partial clinical hold, under which the Company is cleared to begin a modified multiple-doseRead More

Biotech Insider Buying: Synageva BioPharma Corp. (NASDAQ:GEVA), TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), CorMedix (NYSEMKT: CRMD)

January 14, 2015 at 2:02 pm 0 comments

Director Julian Baker acquired 1,000,000 shares of Synageva BioPharma Corp. (NASDAQ:GEVA) stock in a transaction that occurred on Wednesday, January 7th. The shares were purchased at an average cost of $94.19 per share, for a total transaction of $94,190,000.00. OnRead More